Siddhesh Joshi (Editor)

Kevin W Sharer

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Spouse(s)  married
Children  two
Name  Kevin Sharer

Kevin W. Sharer wwwhbsedufacultyProfile20Filessharer24b8366
Born  March 2, 1948Clinton, Iowa
Occupation  CEO and Chairman of the board, Amgen Inc.
Education  University of Pittsburgh (1982), United States Naval Academy (1971), United States Naval Academy (1970)

Kevin W. Sharer (b. Mar. 2, 1948, Iowa) is an American businessman who held positions as CEO and Board member of several large corporations. He has achieved success in leadership, management and governance in innovative fast growing companies.

Contents

Education

Sharer studied aeronautical engineering at the U.S. Naval Academy from approximately 1968 through 1971. He earned a B.S. in engineering 1970 and an M.A. in 1971. He later received his MBA from the University of Pittsburgh's Joseph M. Katz Graduate School of Business in 1983.

Naval career

As an engineering graduate, Sharer served in the navy from 1971 through 1978. He served on two naval fast-class nuclear submarines. At the age of 27, he became the chief engineer on the USS Memphis (SSN-691) overseeing her construction and her crew's training. He left the navy with the rank of lieutenant commander.

Corporate experience

From 1978 to 1982, Sharer worked at AT&T and simultaneously earned an MBA degree from the University of Pittsburgh. Sharer briefly spent time in a consulting position with McKinsey & Company, a management consulting firm.

In 1984 Sharer joined General Electric (GE), where he served in several executive roles in corporate development. In 1989, Sharer left GE for an executive vice president position in marketing at MCI Telecommunications Corporation, where he stayed until 1992.

In 1992, he joined biotech company Amgen, Inc. as president from October 1992 to May 2010 and chief operating officer from 1992 to 2000. He was also a director of Amgen Inc. from November 1992 to December 31, 2012. Amgen was then world’s largest biotechnology company, but small when compared to large pharmaceutical organizations. Some criticized the choice of someone without a medical or chemical degree for the position, but his predecessor at Amgen, Gordon Binder felt that the company already had enough people with strong science backgrounds. Instead, Sharer’s corporate experience was what was sought after by Amgen. Nevertheless, Sharer took a 'crash course' in biotechnology, taking six months of half-sabbatical to immerse himself in the study of biotech issues. Sharer even reportedly hired his old firm, McKinsey, to tutor him in pharmaceuticals and biochemistry.

After 20 years leading Amgen, it was announced that Sharer would retire at the end of 2012. A spokesperson for Amgen credited Sharer with the company's success. During his tenure annual revenue had reached nearly $16 billion with operations in 55 countries, up from $3.6 billion in revenue and a presence in 17 countries before he assumed the top jobs.

Lecturing

In 2012 Sharer joined Harvard Business School as a senior lecturer in business administration teaching corporate strategy.

Boards on which Sharer served as a director

Sharer has served on the boards of several companies:

Geotek Communications Inc. since 1994

Northrop Grumman Corporation from December 16, 2003 to May 20, 2015 (later renamed Titan II Inc.)

Chevron Corporation from 2007 to May 27, 2015

Independent director of Unocal Corporation since June 1, 1997

3M Company from 2001 to May 8, 2007

Micromet, Inc. from March 2, 2012 to March 7, 2012

Independent non-executive director of Allied Minds plc since June 5, 2015

Other positions

  • Chairman of Pharmaceutical Research and Manufacturers of America from 2005 to 2007
  • Trustee California Institute of Technology
  • Chairman of the board of trustees Los Angeles County Museum of Natural History
  • Board of directors U.S. Naval Academy Foundation
  • Trustee National Parks Conservation Association
  • References

    Kevin W. Sharer Wikipedia


    Similar Topics
    Lisa M Buttenheim
    Kumar Mahadevan
    Allieu Kondewa
    Topics
     
    B
    i
    Link
    H2
    L